NEW Zealand Medicines and Medical Devices Safety Authority, Medsafe, has issued an alert communication saying that natural dietary supplement joint-health and joint-mobility product Arthrem carries "potential risk of harm to the liver".
Arthrem soft gel capsules contain 150 mg of Artemisia annua extract in grape seed oil and are registered on the ARTG for sale in Australia, sponsored by Promisia Australia.
Medsafe says the Centre for Adverse Reactions Monitoring (CARM) has received 14 reports of liver toxicity associated with the use of Arthrem.
See medsafe.govt.nz for more.
The above article was sent to subscribers in Pharmacy Daily's issue from 19 Feb 18
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 19 Feb 18
